Evotec signs deal with Sandoz for Just - Evotec Biologics site
Source: SeekingAlpha
2025-11-04 17:02:40 ET
More on Evotec SE, Sandoz Group AG
- Sandoz Group AG (SDZNY) Q3 2025 Sales Call Transcript
- Sandoz Group AG (SDZNY) Q3 2025 Sales/ Trading Statement Call - Slideshow
- Evotec SE (EVO) Q2 2025 Earnings Call Transcript
- Regeneron settles patent dispute with Sandoz over Eylea biosimilar
- Evotec SE reports 1H results
Read the full article on Seeking Alpha
For further details see:
Evotec signs deal with Sandoz for Just - Evotec Biologics site
Sandoz Group AG
NASDAQ: SDZNY
SDZNY Trading
2.66% G/L:
$82.84 Last:
3,730 Volume:
$81.81 Open:
SDZNY Latest News
September 24, 2025 04:15:00 pm
Sandoz launches affordable iron sucrose injection for treatment of iron deficiency anemia in patients with chronic kidney disease in US
August 27, 2025 07:30:00 am
Sandoz welcomes Quebec government support for Boucherville plant modernization project
August 12, 2025 01:00:00 am
Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
August 07, 2025 01:00:00 am
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
